| Income Statement | 2025-09-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|
| Loss from operations | -249 | -228 | -299 | |
| Interest expense | 9 | 2 | 2 | |
| Gain on patent assignment | - | - | 880 | |
| Net loss | -258 | -230 | 579 | |
| Net loss per share, basic | 0 | 0 | 0 | |
| Net loss per share, diluted | 0 | 0 | 0 | |
| Weighted average shares outstanding, basic | 289,156,340 | 286,467,487 | 284,289,740 | |
| Weighted average shares outstanding, diluted | 289,156,340 | 286,467,487 | 284,289,740 | |
Cavitation Technologies, Inc. (CVAT)
Cavitation Technologies, Inc. (CVAT)